CRIS

Curis, Inc. CRIS

CRIS
Curis, Inc. ENTO
Entero Therapeutics, Inc. PCSA
Processa Pharmaceuticals, Inc. BCTX
BriaCell Therapeutics Corp. CTXR
Citius Pharmaceuticals, Inc. LPTX
Leap Therapeutics, Inc. PALI
Palisade Bio, Inc. ATHA
Athira Pharma, Inc. ASBP
Aspire Biopharma Holdings, Inc. HOTH
Hoth Therapeutics, Inc.

Résultat net

EBITDA

P/E Ratio

Capitalisation

Performance

Periode CRIS ENTO PCSA BCTX CTXR LPTX PALI ATHA ASBP HOTH
6M -51.61 % 89.21 % -46.58 % -72.39 % -33.28 % 314.45 % 203.16 % 131.09 % -59.52 % -12.61 %
YTD -75.24 % 35.57 % -84.41 % -90.70 % -79.37 % -63.66 % 18.28 % 31.09 % -99.16 % 35.05 %
1Y -66.56 % 39.15 % -85.33 % -89.93 % -75.81 % -60.74 % 24.29 % 33.77 % -99.16 % 36.84 %
3Y -88.83 % -98.74 % -99.40 % -98.74 % -96.02 % -72.98 % -91.85 % -75.81 % -99.16 % -66.12 %
5Y -99.33 % -100.00 % -99.90 % -98.68 % -97.01 % -94.71 % -99.94 % -97.74 % -99.16 % -97.48 %
10Y -99.63 % -100.00 % -99.56 % 5 226.92 % -99.88 % -98.51 % -100.00 % -95.79 % -99.16 % -99.51 %
Depuis le début -99.96 % -100.00 % -99.96 % 1 644.55 % -99.79 % -98.51 % -100.00 % -95.79 % -99.16 % -99.51 %

Dividende